---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "X2nI0C1ZJGxbN+3Yf+hpsAho4XsWr4zirSHxGhLoy0ghJWLtahjy47/O0YWSG4d5ZzQaxaZMNmLj0lPVBqtMtDILG4GJ1S71vosUd9uiY23/FxqWiMVXtLg9qtIbqCyixmmUxHUXd2Js7ou3uQuqcyXVOogX50zN/ENnAnmEDtSTF14Vqyu2E9jtkxtmlLKs5TqOEyYQk8ZYC2CkOo1uZ7yV1nUsslr/OIybWMNLb4Y7yiZCnLBGb1nbqQI1J3A/8MvtIqLBDxu8+VUcw1MQhYq6ToVm5vA//hcsl2ErRWd6ZSAIbrlNAVJbo3cWqu+U;Wol2BcJQz0jfywbwpDPAOw=="
---

